HMGI Family Proteins: Architectural Transcription Factors in Mammalian Development and Cancer

Keio Journal of Medicine

Volumn 47, Issue 2, 1998, Pages 73-77

  Zhou, Xianjin ^a   Chada, Kiran ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Architectural transcription factors; Cancer; Development; HMGI

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL; GENETICS; HUMAN; MOLECULAR GENETICS; MULTIGENE FAMILY; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; HIGH MOBILITY GROUP PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0032088139     PISSN: 00229717     EISSN: None     Source Type: Journal    
DOI: 10.2302/kjm.47.73     Document Type: Review

References (45)

1. Patterton D, Woffle AP: Developmental roles for chromatin and chromosomal structure. Dev Biol 1996; 173: 2-13
2. Bustin M, Lehn DA, Landsman D: Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990; 1094: 231-234
3. Johnson KR, Lehn D, Elton TS, Barr PJ, Reeves R: Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem 1988; 263: 18338-18342
4. Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, Goodwin GH: cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 1991; 19: 6793-6797
5. Johnson KR, Lehn DA, Reeves R: Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol 1989; 9: 2114-2123
6. Friedmann M, Holth LT, Zoghbi HY, Reeves R: Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res 1993; 21: 4259-4267
7. Zhou X, Benson KF, Ashar HR, Chada K: Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376: 771-774
8. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995; 82: 57-65
9. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berche H, Van de Ven WJ: Recurrent rearrangements in the high mobility group protein gene. HMGI-C, in benign mesenchymal tumours. Nat Genet 1995; 10: 436-444
10. Zhou X, Benson KF, Przybysz K, Liu J, Hou Y, Cherath L, Chada K: Genomic structure and expression of the murine Hmgi-c gene. Nucleic Acids Res 1996; 24: 4071-4077
11. Reeves R, Nissen MS: The A. T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 1990; 265: 8573-8582
12. Thanos D, Maniatis T: The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 1992; 71: 777-789
13. Tjian R, Maniatis T: Transcriptional activation: a complex puzzle with few easy pieces. Cell 1994; 77: 5-8
14. Du W, Thanos D, Maniatis T: Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 1993; 74: 887-898
15. Falvo JV, Thanos D, Maniatis T: Reversal of intrinsic DNA bends in the IFN β gene enhancer by transcription factors and the architectural protein HMGI(Y). Cell 1995; 83: 1101-1111
16. Thanos D, Maniatis T: Virus induction of human IFN β gene expression requires the assembly of an enhanceosome. Cell 1995; 83: 1091-1100
17. Whitley MZ, Thanos D, Read MA, Maniatis T, Collins T: A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 1994; 14: 6464-6475
18. Lewis H, Kaszubska W, DeLamarter JF, Whelan J: Cooperativity between two NF-κB complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol Cell Biol 1994; 14: 5701-5709
19. John S, Reeves RB, Lin JX, Child R, Leiden JM, Thompson CB, Leonard WJ: Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol Cell Biol 1995; 15: 1786-1796
20. Leger H, Sock E, Renner K, Grummt F, Wegner M: Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol Cell Biol 1995; 15: 3738-3747
21. Abdulkadir SA, Krishna S, Thanos D, Maniatis T, Strominger JL, Ono SJ: Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J Exp Med 1995; 182: 487-500
22. Chuvpilo S, Schomberg C, Gerwig R, Heinfling A, Reeves R, Grummt F, Serfling E: Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res 1993; 21: 5694-5704
23. Fashena SJ, Reeves R, Ruddle NH: A poly (dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation. Mol Cell Biol 1992; 12: 894-903
24. Kim J, Reeves R, Rothman P, Boothby M: The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line ε RNA promoter. Eur J Immunol 1995; 25: 798-808
25. Lokuta MA, Maher J, Noe KH, Pitha PM, Shin HS: Mechanism of murine RANTES chemokine gene induction by Newcastle disease virus. J Biol Chem 1996; 271: 13731-13738
26. Vartiainen E, Palvimo J, Mahonen A, Linnala-Kankkunen A, Maenpaa PH: Selective decrease in low-Mr HMG proteins HMG I and HMG Y during differentiation of mouse teratocarcinoma cells. FEBS Lett 1988; 228: 45-48
27. Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Philp R, Crane-Robinson C, Nicolas RH, Wright CA, Goodwin GH: Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by contransfection with c-myc and polyoma middle T genes. EMBO J 1987; 6: 1981-1987
28. Xiang X, Benson KF, Chada K: Mini-mouse: disruption of the pygmy locus in a transgenic insertional mutant. Science 1990; 247: 967-969
29. Chiappetta G, Bandiera A, Berlinguieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A: The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 1995; 10: 1307-1314
30. Fletcher JA, Kozakewich HP, Schoenberg ML, Morton CC: Cytogenetic findings in pediatric adipose tumors: consistent rearrangement of chromosome 8 in lipoblastoma. Genes Chromosomes Cancer 1993; 6: 24-29
31. Fejzo MS, Yoon SJ, Montgomery KT, Rein MS, Weremowicz S, Krauter KS, Dorman TF, Fletcher JA, Mao JI, Moir DT, Kucherlapati R, Morton C: Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 1995; 26: 265-271
32. Feuerstein R, Wang X, Song D, Cooke NE, Liebhaber SA: The LIM/double zinc-finger motif functions as a protein dimerization domain. Proc Natl Acad Sci U S A 1994; 91: 10655-10659
33. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992; 71: 691-700
34. Williams AJ, Powell WL, Collins T, Morton C: HMGI(Y) expression in human uterine leiomyomata. Involvement of another high mobility group architectural factor in a benign neoplasm. Am J Pathol 1997; 15: 911-918
35. Xiao S, Lux ML, Reeves R, Hudson TJ, Fletcher JA: HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchmal cells from pulmonary harmartoma. Am J Pathol 1997; 150: 901-910
36. Tkachenko A, Ashar HR, Meloni AM, Sandberg AA, Chada KK: Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res 1997; 57: 2276-2280
37. Mandahl N, Hoglund M, Mertens F, Rydholm A, Willen H, Brosjo O, Mitelman F: Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 1994; 9: 207-215
38. Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, Goodwin GH: cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 1991; 19: 6793-6797
39. Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH: Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 1989; 184: 538-545
40. Tamimi Y, van der Poel HG, Denyn MM, Umbas R, Karthaus HF, Debruyne FM, Schalken JA: Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 1993; 53: 5512-5516
41. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A: Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995; 15: 1545-1553
42. Lanahan A, Williams JB, Sanders LK, Nathans D: Growth factor-induced delayed early response genes. Mol Cell Biol 1992; 12: 3919-3929
43. Reeves R, Langan TA, Nissen MS: Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. Proc Natl Acad Sci U S A 1991; 88: 1671-1675
44. Meijer L, Ostvold A, Walass SI, Lund T, Laland SG: High-mobility-group protein P1, I and y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase. Eur J Biochem 1991; 196: 557-567
45. Saitoh Y, Laemmli UK: Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 1994; 76: 609-622